| Mrs Dana Foster Mcafee, NP | |
|
10160 Dorchester Road, Summerville, SC 29485 | |
| (843) 871-7900 | |
| Not Available |
| Full Name | Mrs Dana Foster Mcafee |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 10160 Dorchester Road, Summerville, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063180990 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 25285 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Musc Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolina Family Care Inc | 4587557731 | 62 |
News Archive
The decision by nursing homes whether or not to treat an ill resident on-site or send them to a hospital are often linked to that person's insurance status. A new study out this month shows that on average individuals enrolled in Medicaid are 27 percent more likely to be sent to the hospital than individuals with private insurance - decisions that often result in higher costs of care and poor health outcomes.
A Dartmouth Atlas report that studied Medicare beneficiaries concluded that hospital readmission rates are largely static. Facilities will face financial penalities next year if they do not improve their statistics.
The findings reveal that the two-dose regimen of the vaccine is almost 90% effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Moreover, the vaccine shows high efficacy against the B.1.1.7 variant (Alpha) of SARS-CoV-2.
Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.
› Verified 2 days ago
| Entity Name | Doctors Care, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366499048 PECOS PAC ID: 6204731300 Enrollment ID: O20040112000069 |
News Archive
The decision by nursing homes whether or not to treat an ill resident on-site or send them to a hospital are often linked to that person's insurance status. A new study out this month shows that on average individuals enrolled in Medicaid are 27 percent more likely to be sent to the hospital than individuals with private insurance - decisions that often result in higher costs of care and poor health outcomes.
A Dartmouth Atlas report that studied Medicare beneficiaries concluded that hospital readmission rates are largely static. Facilities will face financial penalities next year if they do not improve their statistics.
The findings reveal that the two-dose regimen of the vaccine is almost 90% effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Moreover, the vaccine shows high efficacy against the B.1.1.7 variant (Alpha) of SARS-CoV-2.
Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.
› Verified 2 days ago
| Entity Name | Carolina Family Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184655722 PECOS PAC ID: 4587557731 Enrollment ID: O20040203000627 |
News Archive
The decision by nursing homes whether or not to treat an ill resident on-site or send them to a hospital are often linked to that person's insurance status. A new study out this month shows that on average individuals enrolled in Medicaid are 27 percent more likely to be sent to the hospital than individuals with private insurance - decisions that often result in higher costs of care and poor health outcomes.
A Dartmouth Atlas report that studied Medicare beneficiaries concluded that hospital readmission rates are largely static. Facilities will face financial penalities next year if they do not improve their statistics.
The findings reveal that the two-dose regimen of the vaccine is almost 90% effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Moreover, the vaccine shows high efficacy against the B.1.1.7 variant (Alpha) of SARS-CoV-2.
Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Dana Foster Mcafee, NP 10160 Dorchester Road, Summerville, SC 29485 Ph: (843) 887-1479 | Mrs Dana Foster Mcafee, NP 10160 Dorchester Road, Summerville, SC 29485 Ph: (843) 871-7900 |
News Archive
The decision by nursing homes whether or not to treat an ill resident on-site or send them to a hospital are often linked to that person's insurance status. A new study out this month shows that on average individuals enrolled in Medicaid are 27 percent more likely to be sent to the hospital than individuals with private insurance - decisions that often result in higher costs of care and poor health outcomes.
A Dartmouth Atlas report that studied Medicare beneficiaries concluded that hospital readmission rates are largely static. Facilities will face financial penalities next year if they do not improve their statistics.
The findings reveal that the two-dose regimen of the vaccine is almost 90% effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Moreover, the vaccine shows high efficacy against the B.1.1.7 variant (Alpha) of SARS-CoV-2.
Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.
› Verified 2 days ago
Nicholas Arthur Hathaway, FNP, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 213 W 4th St N, Summerville, SC 29483 Phone: 843-873-0681 | |
Marie Davis Rataj, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 92 Springview Lane, South Carolina Sleep Medicine, Summerville, SC 29485 Phone: 843-871-4006 Fax: 843-871-4074 | |
Mrs. Caroline M Yerich, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 809 N Cedar St, Summerville, SC 29483 Phone: 843-871-9440 Fax: 843-871-5932 | |
Susan Marie Taylor, MSN, APRN, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 148 Apache Dr, Summerville, SC 29483 Phone: 843-708-0694 | |
Kristina M Dibartolo, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 90 Springview Ln # A, Summerville, SC 29485 Phone: 843-832-9113 Fax: 843-832-9114 | |
Jody Kay Smith, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 89 Old Trolley Rd Ste 200, Summerville, SC 29485 Phone: 737-226-6740 | |
Katherine Ellis, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2016 1st Ave, Summerville, SC 29486 Phone: 843-432-3109 |